QDELQuidelOrtho Corporation
Price
-55%1YEnd-of-day closes, not the intraday tick.
The checks lean against it
Quality shaky, a flag to check, growth fading, the market against it.
Charts
As reported to the SEC, without any scoring.
QuidelOrtho Corporation (QDEL) reported revenue of $631M in Q2 2026 (quarter ended Jun 28, 2026), up 2.8% from the same quarter a year earlier. That came with a gross margin of 43% and net loss of $93M. For the full year FY2025, revenue was $2.73B (−1.9% year on year) and net income −$1.13B. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 23, 2026On September 23, 2026, QuidelOrtho Corporation (the “Company”) entered into Amendment No. 1 (the “Amendment”) to its existing credit agreement, dated as of August 21, 2025 (as amended by the Amendment, the “Credit Agreement”), by and among the Company, as borrower, Bank of America, N.A., as administrative agent and …Material agreement entered · Form 8-K
- Aug 6, 2026QuidelOrtho Reports Second Quarter 2026 Financial Results.Earnings release · press release
- Jun 23, 2026Announcement of New Chief Financial Officer The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to serve as the Company’s Chief Financial Officer and principal financial officer, effective as of July 6, 2026 (the “Effective Date”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
Ranks #28 of 51 by RyuScore